Ambu ASAMBBY -0.53%84 EV-to-FCF is 41.99 as of Jun. 30, 2026, which is 26% below its 10-year median of 56.62. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.84 (Significantly Undervalued). Among 419 Medical Devices & Instruments companies, Ambu AS ranks worse than 71.84% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ambu AS's Enterprise Value is $2,450.2 Mil.
Ambu AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $58.4 Mil. Therefore, Ambu AS's EV-to-FCF for today is 41.99.
The historical rank and industry rank for Ambu AS's EV-to-FCF or its related term are showing as below:
AMBBY'
s EV-to-FCF Range Over the Past 10 Years
Min: -2504.51 Med: 56.62 Max: 1521.31
Current: 41.99
During the past 13 years, the highest EV-to-FCF of Ambu AS was 1521.31. The lowest was -2504.51. And the median was 56.62.
AMBBY's EV-to-FCF is ranked worse than 71.84% of 419
companies
in the Medical Devices & Instruments industry
Industry Median: 22.57
vs AMBBY: 41.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ambu AS's share price for today is $9.38.
Ambu AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.279.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ambu AS EV-to-FCF Related Terms
Ambu AS EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Ambu AS's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ambu AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Ambu AS's EV-to-FCF falls into.
Ambu AS's current Enterprise Value is $2,450.2 Mil.
Ambu AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $58.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambu AS (AMBBY) has a EV-to-FCF of 41.99 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Ambu AS and its competitors. This is 26% below median its historical median of 56.62. According to the industry distribution chart, Ambu AS ranks #301 out of 419 companies in the Medical Devices & Instruments industry, placing it in the top 71.8%.
Is Ambu AS's EV-to-FCF too high?
Ambu AS's current EV-to-FCF of 41.99 is 26% below median its 10-year median of 56.62. The Medical Devices & Instruments industry median EV-to-FCF is 22.57. Ambu AS's value of 41.99 is 86% above this industry median. Based on the distribution chart, Ambu AS ranks #301 out of 419 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #301 out of 419 companies for EV-to-FCF. This places Ambu AS in the lower half of its industry. The industry median EV-to-FCF is 22.57. Ambu AS's value of 41.99 is 86% above this benchmark. While the company's 10-year median is 56.62 vs. the industry median of 22.57, Ambu AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.57, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambu AS's current EV-to-FCF of 41.99 is 86% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Ambu AS and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambu AS's current EV-to-FCF is 41.99, which is 26% below median its own 10-year median of 56.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.84, compared to a current price of $9.38 — trading 52.7% below its estimated fair value. The current EV-to-FCF is 41.99, which is 26% below median its 10-year median of 56.62 and 86% above the Medical Devices & Instruments industry median of 22.57. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Ambu AS (AMBBY), the current EV-to-FCF is 41.99 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (AMBBY) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of $9.38 is trading 52.7% below its estimated GF Value™ of $19.84.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for AMBBY:
EV-to-FCF: 41.99 (26% below median its 10-year median of 56.62)
GF Value™: $19.84 vs. price of $9.38 (52.7% below fair value)
Industry Position: 86% above the Medical Devices & Instruments median (#301 of 419)
No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score
Get the complete analysis for AMBBY
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMBBY has been successfully added to your 
